top of page

Takeda receives $38m grant to help eradicate polio

Takeda has received $38 million grant from the Bill & Melinda Gates Foundation to support global polio eradication in developing countries.

With this funding, Takeda will develop, license and supply at least 50 million doses per year of Sabin-strain inactivated poliovirus vaccine (sIPV) to more than 70 developing countries. The vaccine will be manufactured at Takeda’s facility in Hikari, Japan.


Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/40997/news/industry-news/takeda-gates-polio/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page